Entecavir Tablet, Film Coated
Product Images NDC 70771-1019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Entecavir (NDC 70771-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5856a358 F588 4855 A329 Be4bcc173c4a 02

5856a358 F588 4855 A329 Be4bcc173c4a 02
This is a description for Entecavir tablets, which are used for treating hepatitis B viral infection. The tablets must be stored at a temperature between 20 to 25°C and be protected from light. Pharmacists are advised to dispense the tablets in a tightly closed container that should be kept out of reach of children. This medication is available only with a prescription from a doctor. The provided text also mentions the manufacturer of the product is Niaiods in Ahmedabad, India.*
FDA Label Image

5856a358 F588 4855 A329 Be4bcc173c4a 03

5856a358 F588 4855 A329 Be4bcc173c4a 03
Entecavir tablets, with NDC 70771-1020, are used to treat hepatitis B. Each tablet contains 1mg of the active ingredient. The tablets are sensitive to temperature and should be kept at room temperature, protected from light. The packaging should only be opened when required. The pharmacist should provide patient information separately to each patient. The medication should be kept out of reach of children. This medication is manufactured by Gaydus Reonlys and is sold under the brand name iismosens™.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.